🔥🐔 BizChicken 🐔🔥

Learn About the Corporations Around You

Sign Up Today!

Sign up for BizChicken and discover more about the corporations around you.

KalVista Pharmaceuticals, Inc.

KalVista Pharmaceuticals, Inc. logo
Market Cap: Medium
Employees: Low

KVD001, sebetralstat, KVD824, Factor XIIa

Kal Vista Pharmaceuticals, Inc. is a clinical stage pharmaceutical company focused on discovering, developing, and commercializing small molecule protease inhibitors for diseases with unmet needs, including hereditary angioedema and diabetic macular edema.

Tags: Clinical Trials, Diabetic Macular Edema, Hereditary Angioedema, Pharmaceuticals, Protease Inhibitors

Symbol: KALV

Recent Price: $8.39

Industry: Biotechnology

CEO: Mr. Benjamin L. Palleiko

Sector: Healthcare

Employees: 150

Address: 55 Cambridge Parkway, Cambridge, MA 02142

Phone: 857 999 0075

Leadership

  • Albert Cha, Member of Board of Directors
  • William (Bill) Fairey, Member of Board of Directors
  • Benjamin L. Palleiko, Chief Executive Officer and Director
  • Brian J. G. Pereira, Member of Board of Directors
  • Nancy Stuart, Member of Board of Directors
  • Pat Treanor, Member of Board of Directors
  • Edward W. Unkart, Member of Board of Directors

Last updated: 2024-12-31